172. Clin Res Cardiol. 2018 May 2. doi: 10.1007/s00392-018-1264-9. [Epub ahead ofprint]Cardiac autonomic modulation impairments in advanced breast cancer patients.Arab C(1), Vanderlei LCM(2), da Silva Paiva L(3), Fulghum KL(4), Fristachi CE(5),Nazario ACP(6), Elias S(6), Gebrim LH(7), Ferreira Filho C(8), Gidron Y(9),Ferreira C(10).Author information: (1)Departamento de Medicina, Disciplina de Cardiologia, Hospital São Paulo,Escola Paulista de Medicina, Universidade Federal de São Paulo, 715 Napoleão deBarros St, São Paulo, 04024002, SP, Brazil. ac.arabclaudia@gmail.com.(2)Departamento de Fisioterapia, Faculdade de Ciência e Tecnologia, Universidade do Estado de São Paulo, 305 Roberto Símonsen St, Presidente Prudente, SP,19060-900, Brazil.(3)Faculdade de Medicina do ABC, Laboratório de Epidemiologia e Análise de Dados,2000 Lauro Gomes Av, Santo André, SP, 09060-870, Brazil.(4)Department of Physiology and Institute of Molecular Cardiology, School ofMedicine, University of Louisville, Baxter Biomedical Research Building II, 590 SPreston St, Louisville, KY, 40202, USA.(5)Instituto do Câncer Doutor Arnaldo Vieira de Carvalho, 66 Largo do Arouche,São Paulo, SP, 01219-011, Brazil.(6)Departamento de Ginecologia, Hospital São Paulo, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.(7)Centro de Referência da Saúde da Mulher, Hospital Pérola Byington, 683Brigadeiro Luís Antônio Ave, São Paulo, SP, 01317-000, Brazil.(8)Departamento de Medicina, Disciplina de Clínica Médica, Hospital São Paulo,Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo,Brazil.(9)Free University of Brussels (VUB), Boulevard de la Plaine 2, 1050, Ixelles,Belgium.(10)Departamento de Medicina, Disciplina de Cardiologia, Hospital São Paulo,Escola Paulista de Medicina, Universidade Federal de São Paulo, 715 Napoleão deBarros St, São Paulo, 04024002, SP, Brazil.AIM: To compare cardiac autonomic modulation in early- versus advanced-stagebreast cancer patients before any type of cancer treatment and investigateassociated factors.METHODS AND RESULTS: This cross-sectional study included women (30-69 years old) with primary diagnosis of breast cancer and women with benign breast tumors. Weevaluated cardiac modulation by heart rate variability and assessed factors ofanxiety, depression, physical activity, and other relevant medical variables.Patients were divided into three groups based on TNM staging of cancer severity: early-stage cancer (n = 42), advanced-stage cancer (n = 37), or benign breasttumors to serve as a control (n = 37). We analyzed heart rate variability in timeand frequency domains. The advanced-stage cancer group had lower vagal modulationthan early-stage and benign groups; also, the advance-stage group had loweroverall heart rate variability when compared to benign conditions. Heart ratevariability was influenced by age, menopausal status, and BMI.CONCLUSIONS: Heart rate variability seems to be a promising, non-invasive toolfor early diagnosis of autonomic dysfunction in breast cancer and detection ofcardiovascular impairments at cancer diagnosis. Cardiac autonomic modulation isinversely associated with breast cancer staging.DOI: 10.1007/s00392-018-1264-9 PMID: 29721647 